Role of Ras and Mapks in TGFbeta signaling

Area of Science:

• Cellular signaling pathways
• Molecular biology
• Cancer research

Background:

• Transforming growth factor beta (TGFbeta) is a key regulator of cellular processes, including proliferation and differentiation.
• Understanding TGFbeta signaling is crucial for deciphering its role in development and diseases like cancer.

Purpose of the Study:

• To elucidate the intricate mechanisms of TGFbeta-induced TGFbeta1 production and signaling.
• To investigate the interplay between Ras/Erk and Smad pathways in TGFbeta signaling.

Main Methods:

• Utilized dominant-negative constructs (RasN17, DN MKK4, DN Smad3) and a MEK1 inhibitor (PD98059) to dissect signaling pathways.
• Employed AP-1 complex analysis, supershift assays, and reporter gene assays (SBE-luc) to study promoter activity and protein interactions.
• Investigated Smad1 phosphorylation and its impact on protein localization and transcriptional activity.

Main Results:

• TGFbeta rapidly activates Ras, Erks, and Sapks, leading to AP-1 complex formation and TGFbeta1 autoinduction, dependent on JunD and Fra-2.
• TGFbeta autoinduction is Smad3-dependent, but Smad4 is not involved in TGFbeta1 promoter activity.
• TGFbeta activates both MKK4/Sapk and MEK/Erk pathways, with Ras and TGFbeta receptors mediating the induction of TGFbeta1 production.
• Ras/Mapk pathway activation positively modulates Smad1 signaling, and Erk-mediated phosphorylation of Smad1 is critical for its nuclear localization and TGFbeta-dependent transcription.

Conclusions:

• TGFbeta signaling involves a complex cross-talk between Ras/Erk and Smad pathways.
• Erk-mediated phosphorylation of Smad1 is a critical regulatory step for TGFbeta-dependent gene expression.
• These findings provide insights into TGFbeta's role in cellular processes and cancer, highlighting potential therapeutic targets.